GENE ONLINE|News &
Opinion
Blog

Alexion Pharmaceuticals
GeneOnline’s Weekly News Highlights: July 24-28
2023-08-01
Alexion Snaps Up LogicBio Seeking Expansion into Genomic Medicines
2022-10-03
China’s CANbridge Reports Positive Phase 1 Data of Contender to AstraZeneca’s Complement Inhibitor
2022-02-08
AstraZeneca Acquires Caelum in $500m Deal to Strengthen Rare Diseases Division
2021-09-30
BridgeBio Bags First FDA Nod with Rare Disease Drug Acquired from Alexion
2021-03-03
GeneOnline’s Top Mergers and Acquisitions of 2020
2020-12-30
AstraZeneca to Acquire Alexion for US$ 39 Billion to Grow Immunology Pipeline
2020-12-13
Taiwanese Government Grants 16 Million to aid Adimmune’s COVID-19 Vaccine Trials
2020-10-24
Efforts Behind the Taiwan Model of Combating COVID-19 Pandemic
2020-07-26Partner
Weekly in Asia|Nov-1
2019-11-19
LATEST
Oncology’s New Drugs on the Horizon (II): Radiotherapy, Radioligands & Other Therapeutic Agents
2024-04-12
Oncology’s New Drugs on the Horizon (I): Cancer Immunotherapy and Targeted Therapy
2024-04-12
Vertex Pharmaceuticals Makes $4.9 Billion Bet on Kidney Disease Treatment through Alpine Immune Acquisition
2024-04-11
Bayer Signs New Partnership with Google Cloud, Joining Hands for AI Solutions for Radiologists
2024-04-10
Pharmacogenomics (PGx) Shaping the Dynamic APAC Regions
2024-04-10
Connecting Biotech Ecosystems: Success of Los Angeles Event Sets Stage for APAC-US Collaboration
2024-04-10
Innovating Prostate Cancer Care: SYNC-T, Proteogenomics, and Culturally Tailored Education at AACR 2024
2024-04-10
EVENT
Scroll to Top